The Vaccination Station

Rare Rubio W.

👍

--WASHINGTON/LONDON, June 2 (Reuters) - U.S. Secretary of ​State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak ‌in several African countries.

Rubio told the Senate Foreign Relations Committee that the decision had been made a few weeks ago to re-engage, after the Trump administration pulled funding from Gavi last year.

..Rubio said that Secretary Kennedy had taken a leading role in determining what was going to happen next with Gavi, but the State Department would now re-engage because "we need to drive this to an outcome".

"The State Department a few weeks ago made the decision that we were going to re-engage on this issue of Gavi, respecting what ​HHS' (Department of Health and Human Services) views are on it as well," Rubio said.

"We'd like to get this issue resolved in an outcome that's ​acceptable both to Congress and also to our goals on global health."

US to re-engage with Gavi vaccine alliance amid Ebola outbreak, Rubio says U.S. Secretary of ​State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak ‌in several African countries.

Sources:

https://orcid.org/0000-0003-4344-0754

https://pmc.ncbi.nlm.nih.gov/articles/PMC8255173

https://www.sciencedirect.com/science/article/pii/S2214750026000521

https://forbetterscience.com/2023/09/18/lashing-out-at-toxicology-reports

https://retractionwatch.com/2026/05/26/elsevier-retracts-study-tying-sudden-infant-death-syndrome-to-vaccinations

Anti-vaxxers lie frequently, and so do their bots.

👀

--President Donald Trump on Friday gave his endorsement to a January study by HHS that calls for cutting the number of vaccines recommended for every American child.

An executive order from Trump directs federal agencies to align their policies behind the study, which recommended an overhaul long called for by HHS Secretary Robert F. Kennedy Jr. The study found that the U.S. recommends more childhood vaccines than many peer nations.

The Trump administration previously moved to narrow the number of recommended childhood vaccines in response to the report, but the move was blocked by a federal judge in Massachusetts. The administration is appealing the decision.

The study recommends vaccinating all children against 11 diseases. Several others would be recommended only for high-risk groups or when doctors recommend them in what's called "shared decision-making."

That includes vaccines for flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis, and respiratory syncytial virus (RSV).

There's no credible scientific evidence to support changing the current childhood schedule, said Bobby Mukkamala, MD, president of the American Medical Association.

https://archive.md/wip/DF7PB

https://www.medpagetoday.com/infectiousdisease/vaccines/121507

Borax groups continue to flourish on Facebook. Members swap treatment protocols, and offer advice for medically treating each other's children with this common household cleaning agent.

Lara Logan thinks this blatantly false meme (which includes the nonsensical and meaningless claim, '1048% spike in the nervous system') is evidence of COVID vaccine consequences.

It has no references, no cited sources; it's just a bunch of imaginary numbers in an image shared by ivermectin quack Mary Talley Bowden.

An equally credulous commenter claims the vaccine is 'a bio cyber interface' that 'connects people to the cloud.'

https://x.com/johnsmith168944/status/2057620082751394036

🤔

👀

Lindsey shows off the hilarious laundry list of lies she crammed into her VAERS report. I can't reply to her, because she's blocked me. They all block me, eventually.

🤔

https://x.com/SusanNi45698885/status/2057152968147739101

--May 26 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it will buy three vaccine ‌developers in deals worth up to $3.8 billion in combined value, signaling its push into infectious disease prevention.

The U.S. drugmaker said it had agreed to acquire Curevo, LimmaTech Biologics and Vaccine Company.

Lilly has been on an ​acquisition spree, boosted by cash from the booming demand for its obesity drugs. ​Its deal spending in 2026 has outpaced that in the prior years.

Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push Eli Lilly said on Tuesday it will buy three vaccine ‌developers in deals worth up to $3.8 billion in combined value, signaling its push into infectious disease prevention.